New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc.
Industry: Life Sciences ・ $BBIO on Nasdaq ・ Market Cap: Medium
CEO Recent Sales
Top Executive Recent Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 0 / 14 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 0 / 6 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 0 / 6,053,071 0 / 432,362 |
| VALUE PURCHASED/SOLD Transaction Average | $0 / $157,751,071 $0 / $11,267,934 |
| PURCHASE RANGE | N/A |
| SALE RANGE | $73,125 - $149,350,000 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
0 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
1 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
No Insider Trades made
0%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.2 |
VALUE GINI INDEX Sector Average | N/A 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
2.8%
DIRECTORS
0.14%
OFFICERS
97.06%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.802 0.295 |
VALUE GINI INDEX Sector Average | 0.807 0.288 |
BridgeBio Pharma, Inc. 1Y Trade Transactions